MedPath

Changchun GeneScience Pharmaceutical Co., Ltd.

🇨🇳China
Ownership
-
Established
1948-01-01
Employees
-
Market Cap
-
Website
http://english.ciac.cas.cn/

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Phase 4
Conditions
Dwarfism, Pituitary
Interventions
Biological: PEG-somatropin
First Posted Date
2014-12-11
Last Posted Date
2014-12-11
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Target Recruit Count
900
Registration Number
NCT02314676
Locations
🇨🇳

First People's Hospital of Wuhu, Wuhu, Anhui, China

🇨🇳

Children's Hospital Affiliated to Zhejiang University, Hangzhou, Zhejiang, China

Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn

Phase 4
Completed
Conditions
Deep Partial Thickness Burn
Interventions
First Posted Date
2013-02-07
Last Posted Date
2013-02-07
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Target Recruit Count
2510
Registration Number
NCT01785784

Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children

Phase 1
Completed
Conditions
Growth Hormone Deficiency
First Posted Date
2012-06-07
Last Posted Date
2012-06-14
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Target Recruit Count
12
Registration Number
NCT01613573

Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Phase 3
Completed
Conditions
Growth Hormone Deficiency
First Posted Date
2011-12-20
Last Posted Date
2017-07-31
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Target Recruit Count
343
Registration Number
NCT01495468

Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children

Phase 2
Completed
Conditions
Growth Hormone Deficiency
First Posted Date
2011-04-27
Last Posted Date
2017-07-31
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Target Recruit Count
101
Registration Number
NCT01342146
© Copyright 2025. All Rights Reserved by MedPath